344 related articles for article (PubMed ID: 19473864)
1. The International Olympic Committee (IOC) and GH-2000.
Sönksen P
Growth Horm IGF Res; 2009 Aug; 19(4):341-5. PubMed ID: 19473864
[TBL] [Abstract][Full Text] [Related]
2. Moving one step closer to catching the GH cheats: The GH-2004 experience.
Holt RI; Bassett EE; Erotokritou-Mulligan I; McHugh C; Cowan D; Bartlett C; Sönksen PH;
Growth Horm IGF Res; 2009 Aug; 19(4):346-51. PubMed ID: 19467613
[TBL] [Abstract][Full Text] [Related]
3. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
4. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
[TBL] [Abstract][Full Text] [Related]
5. IGF-I abuse in sport: current knowledge and future prospects for detection.
Guha N; Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
[TBL] [Abstract][Full Text] [Related]
6. Detection of GH abuse in sport: Past, present and future.
Barroso O; Schamasch P; Rabin O
Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
[TBL] [Abstract][Full Text] [Related]
7. Statistical issues in implementing the marker method.
Bassett EE; Erotokritou-Mulligan I
Growth Horm IGF Res; 2009 Aug; 19(4):361-5. PubMed ID: 19515593
[TBL] [Abstract][Full Text] [Related]
8. Medicine and science in the fight against doping in sport.
Catlin DH; Fitch KD; Ljungqvist A
J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
[TBL] [Abstract][Full Text] [Related]
9. GH & IGF Research issue on doping with growth hormone.
Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
[No Abstract] [Full Text] [Related]
10. 20K-GH and its use in detecting GH abuse.
Irie M; Ueki M; Kishikawa Y; Nishii M; Kawahara T
Growth Horm IGF Res; 2009 Aug; 19(4):352-6. PubMed ID: 19487145
[TBL] [Abstract][Full Text] [Related]
11. Beyond reasonable doubt: catching the growth hormone cheats.
Holt RI
Pediatr Endocrinol Rev; 2007 Mar; 4(3):228-32. PubMed ID: 17551486
[TBL] [Abstract][Full Text] [Related]
12. New detection methods of growth hormone and growth factors.
Bidlingmaier M
Endocr Dev; 2012; 23():52-9. PubMed ID: 23182820
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
[TBL] [Abstract][Full Text] [Related]
14. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets.
Erotokritou-Mulligan I; Bassett EE; Kniess A; Sönksen PH; Holt RI
Growth Horm IGF Res; 2007 Oct; 17(5):416-23. PubMed ID: 17584513
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and the adolescent athlete: What are the data for its safety and efficacy as an ergogenic agent?
Rogol AD
Growth Horm IGF Res; 2009 Aug; 19(4):294-9. PubMed ID: 19487146
[TBL] [Abstract][Full Text] [Related]
16. The history of doping and growth hormone abuse in sport.
Holt RI; Erotokritou-Mulligan I; Sönksen PH
Growth Horm IGF Res; 2009 Aug; 19(4):320-6. PubMed ID: 19467612
[TBL] [Abstract][Full Text] [Related]
17. Overview of the legal framework applicable to the marker method for the detection of human growth hormone.
Young RR; Bielak JS; Horvitz SL
Growth Horm IGF Res; 2009 Aug; 19(4):366-8. PubMed ID: 19608446
[TBL] [Abstract][Full Text] [Related]
18. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
19. Test method: GH.
Bidlingmaier M; Wu Z; Strasburger CJ
Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):99-109. PubMed ID: 10932814
[TBL] [Abstract][Full Text] [Related]
20. Detection of doping with recombinant human growth hormone.
He C; Wu M
Bioanalysis; 2009 Aug; 1(5):953-65. PubMed ID: 21083065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
